we discover ...
The economic hub Bremerhaven opens a gate to the world which is exactly the cosmopolitan openness mir|detect needs to thrive.
Cancer is an international topic.
Many types of cancer are not researched enough yet.
mir|detect creates reliability and certainty not only in the section of testicular cancer.
mir|detect: Biotechnology from Bremerhaven.
Exclusive Distribution Agreement for Europe
with Gold Standard Diagnostics
Presentation of
M371 at the DGU congress in Stuttgart
mir | detect became ISO 13485 certified
M371 became CE certified
after IVDD
Finalist of the
EIT Health Headstart Förderprogramms 2019
Nominated for the
ACHEMA-Gründerpreis 2018
Presentation of the biomarker miR371a at the
9th Copenhagen Workshop on Testikular Germ Cell Cancer
Awarded
Sience4Life Cup 2017
Finalist of the
BioVaria-Kongress 2017 in Munich
Awarded
Venture Lounge 2016
Foundation
mir|detect GmbH
M371 Project started
at the University of Bremen
12th of May 2023
Meeting with Gold Standard Diagnosics in Bremerhaven
On May 12, 2023, we received a visit from a team of our exclusive distribution partner, Gold Standard Diagnostics, at our premises in Bremerhaven.
We are proud to continue the path we started in November 2022 with this well-connected and established partner throughout Europe, and we look forward to further intense and fruitful collaboration.
April 2023
New Gold Standard
21st - 23rd of September 2022
74. Congress of the German Society of Urology
Over three days mir|detect presented the test M371 at the congress of the German Society of Urology at the company's own booth and was available for interested questions.
Prof. Dr. Klaus-Peter Dieckmann shared his latest research findings on miRNA-371a with colleagues as part of the scientific program.
19th - 20th of May 2022
Testicular Cancer Awareness Foundation
mir|detect was presenting M371 at the M371-both at the UroBay in Lindau.
20th - 21st of April 2022
Testicular Cancer Awareness Foundation
mir|detect was happy to provide a platinum sponsorship for this conference.
Jana Frey ( mir|detect - product management ) presented M371 to all participants of the virtual meeting.
7th of October 2021
BioVendor | Laboratorni medicina a.s. | Czech Republic
M371 is now available through BioVendor in Brno, Czech Republic.
15th to the 18th of September 2021
German Association of Urology
mir|detect presents M371 at the annual congress of the German Association of Urology. Interested medical staff had the opportunity to directly ask questions to our team.
15th of June 2021
GeLaMed | Eurofins Laborbetriebsgesellschaft Gelsenkirchen GmbH
M371 is now available at the Eurofins Laboratory in Gelsenkirchen (GeLaMed). M371 can be ordered through your urologist.